B. Horton
Immunology · 2017
A researcher in the Science corpus: 1 paper; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 20 citations into it
- Oncology — 18 citations into it
- Molecular Biology — 9 citations into it
Whom B. Horton trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from B. Horton's perspective
Ordered by how strongly the researchers B. Horton trusts endorse each paper. Same corpus, a different order for every researcher.
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment (Cancer Research)
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
- Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8α+ conventional dendritic cells (Journal of Experimental Medicine)
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer (New England Journal of Medicine)
- Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells (Journal of Experimental Medicine)
- Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen Presenting Cells, Critical for T cell Immunity (Cancer Cell)
- Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes (Science)
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors (Immunity)
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma (Cell)
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. (New England Journal of Medicine)